• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扁平部玻璃体切除术在有晶状体和人工晶状体性恶性青光眼治疗中的应用

Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma.

作者信息

Harbour J W, Rubsamen P E, Palmberg P

机构信息

Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Fla.

出版信息

Arch Ophthalmol. 1996 Sep;114(9):1073-8. doi: 10.1001/archopht.1996.01100140275003.

DOI:10.1001/archopht.1996.01100140275003
PMID:8790091
Abstract

OBJECTIVE

To determine the indications for and outcome of pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma.

DESIGN

Retrospective review.

SETTING

Tertiary referral ophthalmic hospital.

PATIENTS

Twenty-two patients (24 eyes) who underwent pars plana vitrectomy in the management of malignant glaucoma.

RESULTS

Fourteen eyes were phakic and 10 were pseudophakic at the initial vitrectomy. The primary indication for vitrectomy was failure of other therapies. In phakic eyes, the initial vitrectomy was successful in terminating malignant glaucoma without further surgery in 7 (100%) of 7 eyes that underwent lensectomy and in 5 (71%) of 7 eyes that not did not undergo lensectomy. The primary indication for lensectomy was corneal edema caused by lens-corneal touch. In pseudophakic eyes, the initial vitrectomy was successful in 9 (90%) of 10 eyes. Removal of the intraocular lens was performed in 1 eye. Perioperative complications included transient serous choroidal detachment in 2 eyes, transient exudative retinal detachment in 1 eye, and suprachoroidal hemorrhage in 1 eye.

CONCLUSIONS

Pars plana vitrectomy is effective in treating phakic and pseudophakic malignant glaucoma. Success is contingent on establishing a pathway for aqueous flow into the anterior chamber, which usually is accompanied by intraoperative deepening of the anterior chamber. In phakic eyes, lensectomy may be considered for marked corneal edema, for dense cataract, or when the anterior chamber will not deepen during vitrectomy.

摘要

目的

确定平坦部玻璃体切除术在治疗有晶状体和人工晶状体性恶性青光眼中的适应证及疗效。

设计

回顾性研究。

地点

三级转诊眼科医院。

患者

22例(24只眼)因恶性青光眼接受平坦部玻璃体切除术的患者。

结果

初次玻璃体切除术时,14只眼为有晶状体眼,10只眼为人工晶状体眼。玻璃体切除术的主要适应证是其他治疗方法失败。在有晶状体眼中,初次玻璃体切除术成功终止恶性青光眼且无需进一步手术的情况为:7只接受晶状体切除术的眼中有7只(100%),7只未接受晶状体切除术的眼中有5只(71%)。晶状体切除术的主要适应证是晶状体-角膜接触引起的角膜水肿。在人工晶状体眼中,初次玻璃体切除术在10只眼中有9只(90%)成功。1只眼进行了人工晶状体取出术。围手术期并发症包括2只眼出现短暂性浆液性脉络膜脱离,1只眼出现短暂性渗出性视网膜脱离,1只眼出现脉络膜上腔出血。

结论

平坦部玻璃体切除术治疗有晶状体和人工晶状体性恶性青光眼有效。成功取决于建立房水流入前房的通道,这通常伴随着术中前房加深。在有晶状体眼中,对于明显的角膜水肿、致密白内障或玻璃体切除术中前房不加深的情况,可考虑进行晶状体切除术。

相似文献

1
Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma.扁平部玻璃体切除术在有晶状体和人工晶状体性恶性青光眼治疗中的应用
Arch Ophthalmol. 1996 Sep;114(9):1073-8. doi: 10.1001/archopht.1996.01100140275003.
2
Aqueous misdirection after glaucoma drainage device implantation.青光眼引流装置植入术后的房水错流
Ophthalmology. 1999 May;106(5):1035-40. doi: 10.1016/S0161-6420(99)00530-8.
3
Combined pars plana lensectomy-vitrectomy with open-loop flexible anterior chamber intraocular lens (AC IOL) implantation for subluxated lenses.联合扁平部晶状体切除术-玻璃体切除术及开放式可弯曲前房型人工晶状体(AC IOL)植入治疗晶状体半脱位
Trans Am Ophthalmol Soc. 2000;98:247-51; discussion 251-3.
4
Videoendoscope-guided fluorescein-assisted vitrectomy for phakic malignant glaucoma.视频内窥镜引导下荧光素辅助玻璃体切除术治疗有晶状体眼恶性青光眼
Arch Ophthalmol. 2005 Oct;123(10):1419-21. doi: 10.1001/archopht.123.10.1419.
5
Vitrectomy for ciliary block (malignant) glaucoma.睫状环阻滞(恶性)青光眼的玻璃体切除术
Ophthalmology. 1995 Sep;102(9):1308-11. doi: 10.1016/s0161-6420(95)30870-6.
6
Pars plana Baerveldt tube insertion with vitrectomy in glaucomas associated with pseudophakia and aphakia.在伴有人工晶状体眼和无晶状体眼的青光眼患者中,行玻璃体切除术时植入Baerveldt巩膜平坦部引流管
Am J Ophthalmol. 1995 Apr;119(4):401-7. doi: 10.1016/s0002-9394(14)71224-3.
7
Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes.玻璃体切割-超声乳化-玻璃体切割术治疗有晶状体眼房水错流综合征
Ophthalmology. 2006 Nov;113(11):1968-73. doi: 10.1016/j.ophtha.2006.04.031.
8
Surgical management of secondary glaucoma after pars plana vitrectomy and silicone oil injection for complex retinal detachment.复杂性视网膜脱离行玻璃体切割联合硅油注入术后继发性青光眼的手术治疗
Ophthalmology. 2001 Sep;108(9):1628-32. doi: 10.1016/s0161-6420(01)00658-3.
9
Treatment outcomes and efficacy of pars plana vitrectomy-hyaloidotomy-zonulectomy-iridotomy in malignant glaucoma.恶性青光眼行睫状体平坦部玻璃体切除-玻切-巩膜切开-虹膜切开术的治疗效果和疗效。
Eur J Ophthalmol. 2021 Jan;31(1):234-239. doi: 10.1177/1120672119877139. Epub 2019 Oct 7.
10
Phacoemulsification combined with posterior capsulorhexis and anterior vitrectomy in the management of malignant glaucoma in phakic eyes.超声乳化白内障吸除术联合后囊膜切开及前段玻璃体切除术治疗晶状体眼恶性青光眼
Acta Ophthalmol. 2013 Nov;91(7):660-5. doi: 10.1111/j.1755-3768.2012.02451.x. Epub 2012 Jun 7.

引用本文的文献

1
Malignant glaucoma due to dislocated intraocular lens into the vitreous cavity: A case report.人工晶状体脱位至玻璃体腔导致恶性青光眼:一例报告。
Int J Surg Case Rep. 2025 Sep;134:111737. doi: 10.1016/j.ijscr.2025.111737. Epub 2025 Jul 26.
2
Treatment outcomes of pars plana vitrectomy-hyaloidotomy-zonulectomy-iridectomy in malignant glaucoma in a tertiary eye care center in South India.印度南部一家三级眼科护理中心行玻璃体切割术-玻璃体前界膜切开术-晶状体悬韧带切断术-虹膜切除术治疗恶性青光眼的疗效
Indian J Ophthalmol. 2025 Jun 1;73(Suppl 3):S444-S448. doi: 10.4103/IJO.IJO_1556_24. Epub 2025 May 30.
3
Aqueous misdirection syndrome: clinical outcomes and risk factors for treatment failure.
水性迷路综合征:临床结局和治疗失败的风险因素。
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2209-2217. doi: 10.1007/s00417-024-06381-5. Epub 2024 Feb 19.
4
Incidence and characteristics of aqueous misdirection after glaucoma surgery in Chinese patients with primary angle-closure glaucoma.中国原发性闭角型青光眼患者青光眼手术后房水错流的发生率及特征
Eye Vis (Lond). 2023 Jul 1;10(1):28. doi: 10.1186/s40662-023-00346-1.
5
Management of Malignant Glaucoma.恶性青光眼的治疗
J Curr Ophthalmol. 2023 Apr 29;34(4):389-397. doi: 10.4103/joco.joco_147_22. eCollection 2022 Oct-Dec.
6
Outcomes of Medical and Surgical Management in Aqueous Misdirection Syndrome.房水错流综合征的药物及手术治疗结果
Clin Ophthalmol. 2023 Mar 9;17:797-806. doi: 10.2147/OPTH.S385864. eCollection 2023.
7
Predisposing Factors for Severe Complications after Cataract Surgery: A Nationwide Population-Based Study.白内障手术后严重并发症的诱发因素:一项基于全国人口的研究。
J Clin Med. 2021 Jul 28;10(15):3336. doi: 10.3390/jcm10153336.
8
A refractory malignant glaucoma posttrabeculectomy in vitrectomized eye: A case report and review of the literature.玻璃体切除术后小梁切除术后难治性恶性青光眼:一例报告并文献复习
Taiwan J Ophthalmol. 2020 Feb 14;10(4):302-305. doi: 10.4103/tjo.tjo_8_19. eCollection 2020 Oct-Dec.
9
Management of Pseudophakic Malignant Glaucoma in Sunset Syndrome: A Case Report and Literature Review.日落综合征中人工晶状体性恶性青光眼的治疗:一例报告及文献综述
Med Hypothesis Discov Innov Ophthalmol. 2019 Summer;8(2):92-95.
10
Combined Surgical Techniques for the Management of Malignant Glaucoma.用于治疗恶性青光眼的联合手术技术
J Ophthalmol. 2018 Nov 22;2018:9189585. doi: 10.1155/2018/9189585. eCollection 2018.